Abstract:Abstract Background Estrogen receptors (ERs) are thought to play an important role in non-small cell lung cancer (NSCLC). However, the effect of ERs in NSCLC is still controversial and needs further investigation. A new consideration is that ERs may affect NSCLC progression through complicated molecular signaling networks rather than individual targets. Therefore, this study aims to explore the effect of ERs in NSCLC from the perspective of cancer systems biology. Methods The gene expression profile of NSCLC samples in TCGA dataset was analyzed by bioinformatics method. Variations of cell behaviors and protein expression were detected in vitro. The kinetic process of molecular signaling network was illustrated by a systemic computational model. At last, immunohistochemical (IHC) and survival analysis was applied to evaluate the clinical relevance and prognostic effect of key receptors in NSCLC. Results Bioinformatics analysis revealed that ERs might affect many cancer-related molecular events and pathways in NSCLC, particularly membrane receptor activation and signal transduction, which might ultimately lead to changes in cell behaviors. Experimental results confirmed that ERs could regulate cell behaviors including cell proliferation, apoptosis, invasion and migration; ERs also regulated the expression or activation of key members in membrane receptor signaling pathways such as epidermal growth factor receptor (EGFR), Notch1 and Glycogen synthase kinase-3β/β-Catenin (GSK3β/β-Catenin) pathways. Modeling results illustrated that the promotive effect of ERs in NSCLC was implemented by modulating the signaling network composed of EGFR, Notch1 and GSK3β/β-Catenin pathways; ERs maintained and enhanced the output of oncogenic signals by adding redundant and positive-feedback paths into the network. IHC results echoed that high expression of ERs, EGFR and Notch1 had a synergistic effect on poor prognosis of advanced NSCLC. Conclusions This study indicated that ERs were likely to promote NSCLC progression by modulating the integrated membrane receptor signaling network composed of EGFR, Notch1 and GSK3β/β-Catenin pathways and then affecting tumor cell behaviors. It also complemented the molecular mechanisms underlying the progression of NSCLC and provided new opportunities for optimizing therapeutic scheme of NSCLC.

EGF–ERBB signalling: towards the systems level

Untangling the ErbB signalling network

The physical basis of analog‐to‐digital signal processing in the EGFR system—Delving into the role of the endoplasmic reticulum

ERK signalling: a master regulator of cell behaviour, life and fate

Computational modeling of the EGFR network elucidates control mechanisms regulating signal dynamics

The Logic of EGFR/ErbB Signaling: Theoretical Properties and Analysis of High-Throughput Data

Epidermal growth factor receptor (EGFR) and its signal transduction

Structural Basis for EGFR Transmembrane Signaling and Its Implications in Therapeutic Development

Molecular Architecture of the Erbb2 Extracellular Domain Homodimer

Emerging paradigms and recent progress in targeting ErbB in cancers

Eph receptor signalling: from catalytic to non-catalytic functions

The EGF receptor family as targets for cancer therapy

Molecular Targeting of the Human Epidermal Growth Factor Receptor-2 (HER2) Genes across Various Cancers

Cell signaling by receptor tyrosine kinases

Structure and dynamics of the EGFR/HER2 heterodimer

Profiling of ERBB receptors and downstream pathways reveals selectivity and hidden properties of ERBB4 antagonists

Erbb Receptors: From Oncogenes To Targeted Cancer Therapies

Spreading of EGF Receptor Activity into EGF-free Regions and Molecular Therapies of Cancer

Beyond wavy hairs: the epidermal growth factor receptor and its ligands in skin biology and pathology

Systems-based analysis of responses to stimulation or inhibition of EGF receptor signaling in breast cancer cells

Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective